panglobal – Page 95 – International Hospital

REGEnLIFE’s trial of photobiomodulation technology for Alzheimer’s shows promising results

30 March 2021 in E-News /by panglobal

REGEnLIFE, a company specialized in the research and development of innovative photo-medical technologies for the prevention and treatment of neurodegenerative diseases, has seen promising results of the pilot clinical trial evaluating its technology in Alzheimer’s disease (AD). The results were presented by Professor Jacques Touchon, scientific advisor on the trial, at the 15th International Conference on […]

Virtual events – does the industry like them?

29 March 2021 in E-News /by panglobal

Virtual events are likely to remain a firm fixture for some time, but do industry professionals like them? A recent survey found that while more than three quarters of survey respondents from the pharmaceutical and medical device sectors felt that virtual events would become much more popular in future – rivalling face-to-face events in number […]

Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection

4 March 2021 in Corona News, E-News /by panglobal

SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists. Given that both vaccines and therapeutics are aimed at the spike protein, which we saw mutate in our patient, our study raises […]

Hidden genes could be key in development of new antibiotics

4 March 2021 in E-News /by panglobal

A study from the Centre for Phage Technology, part of Texas A&M’s College of Agriculture and Life Sciences and Texas A&M AgriLife Research, shows how the “hidden” genes in bacteriophages – types of viruses that infect and destroy bacteria – may be key to the development of a new class of antibiotics for human health. […]

Critical flaw found in lab models of the human blood-brain barrier

4 March 2021 in E-News /by panglobal

Cells used to study the human blood-brain barrier in the lab aren’t what they seem, throwing nearly a decade’s worth of research into question, a new study from scientists at Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine suggests. The team also discovered a possible way to correct the error, raising […]

About panglobal

Entries by panglobal

REGEnLIFE’s trial of photobiomodulation technology for Alzheimer’s shows promising results

Virtual events – does the industry like them?

Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection

Hidden genes could be key in development of new antibiotics

Critical flaw found in lab models of the human blood-brain barrier

Latest issue of International Hospital

Embedding sustainable principles in the design of drug delivery devices

Hospital hand hygiene monitoring requirements could be safely reduced, study finds

SGLT2 inhibitors emerge as key players in cardiac protection research

Free subscription

Get our e-alert

Author Archive for: panglobal

About panglobal

Entries by panglobal

Latest issue of International Hospital

Free subscription

Get our e-alert